Elon Musk's company Neuralink, which creates brain implants, received approval from the U.S. Food and Drug Administration (FDA) for its first human clinical trial. This is an important achievement after facing difficulties in gaining approval previously.
Neuralink expressed in a tweet that the FDA approval is a significant initial milestone that would eventually enable their technology to assist a large number of individuals.
The company did not provide further information about the study's objectives but stated that they are not accepting participants at the moment and will release more information soon, according to Reuters.
What Neuralink Can Do
Musk has a vision that brain implants could be used to treat multiple health conditions such as obesity, autism, depression, and schizophrenia.
Furthermore, these implants could allow individuals to browse the internet and communicate telepathically. His statement that he would implant them in his own children shows his confidence in their safety.
In 2019, Musk made multiple statements indicating that Neuralink would commence human trials. However, the company did not apply for FDA approval until early 2022, and the application was rejected by the agency, according to seven present and past employees who spoke with Reuters in March.
Concerns Over Neuralink
The FDA has raised certain concerns with Neuralink regarding the need to address several issues before approving human trials. These issues include the lithium battery of the device, the possibility of the implant's wires moving within the brain, and the difficulty of removing the device safely without harming the brain tissue.
(Photo: Wikimedia Commons / Steve Jurvetson) Elon Musk and the Neuralink Future
Neuralink, a company established in 2016, has come under scrutiny by federal authorities on multiple occasions.
Recently, American lawmakers requested that regulators look into whether the composition of a committee responsible for supervising animal testing at Neuralink played a role in poorly executed and hurried experiments.
The Department of Transportation is investigating whether Neuralink unlawfully transported hazardous microorganisms on chips extracted from monkey brains without adequate safety measures in place.
The U.S. Department of Agriculture's Office of Inspector General is currently investigating Neuralink for possible violations of animal welfare. The investigation is also examining the USDA's supervision of Neuralink.
The Long-Term Effects of Neuralink's Technology
In addition to concerns raised by the FDA, some experts have also expressed reservations about the long-term effects of Neuralink's brain implant technology. There are fears that such devices could potentially lead to unintended consequences and even alter a person's personality or behaviors.
Despite these challenges, Elon Musk remains optimistic about Neuralink's future prospects. He has stated that he believes human trials will begin within the next year and hopes that his company can eventually help people with serious brain injuries or conditions like Parkinson's disease.
Neuralink is not alone in its efforts to develop advanced neurotechnology. Other companies like Kernel and Blackrock Microsystems are also working on similar projects, although they may face many of the same regulatory hurdles as Neuralink.
As advancements in neuroscience continue at an unprecedented pace, it remains uncertain what impact these technologies will ultimately have on society. While there is hope for new treatments for neurological disorders and an improved understanding of how our brains work, we must ensure that ethical considerations remain at the forefront of research into this field so as not to compromise individual privacy rights or create unforeseen risks.
Related article: Elon Musk Twitter Headache: Expert Reveals Major Problem After Tesla Stocks Drop
